medigraphic.com

2019, Number 4

<< Back Next >>

Rev Med MD 2019; 10.11 (4)

Screening options for colorectal cancer

González-Duarte JA, Barragán-Sánchez A, Villa-Meda F, Covarrubias-Leos AK, Betancourt-Vicencio S, Carrillo-Valdéz S, Arroniz-Jauregui LA, Magaña-Vaca JF, Hernández-Gómez F, Zepeda- Solís C, Navarro-Lara E, Enciso-Pérez D

Language: Spanish
References: 27
Page: 277-284
PDF size: 564.79 Kb.


ABSTRACT

Colorectal Cancer is a common disease in our environment, its incidence and mortality varies significantly around the world. In our country and Latin America, efforts have been made to improve the diagnostic rates of the RCC and modern screening programs are currently being carried out. To aim for a good CCR screening program, the target population must be established and evaluated. Once the patient's risk is established, various diagnostic options will be chosen, highlighting colonoscopy as “the gold standard” for elevated risk and high-risk patients; while immunochemical fecal tests are recommended for patients with average risk. This review describes the different tools available to create CCR screening programs and recommendations for their use.


REFERENCES

  1. International Agency for Research on Cancer. GLOBOCAN. World Health Organization. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide. 2012. Disponible en: http://globocan. iarc. fr/Pages/Map. aspx. 07/03/2018.

  2. Pan American Health Organization. Tamizaje de Cáncer Colorrectal en las Américas. Situación y Retos. Pan American Health Organization. 2014; 1:12.Disponible en : https://www.paho.org/hq/index.php?option=com _content&view=article&id=11761:colorectalcancer& Itemid=41765&lang=es

  3. 3.Secretaria de Salud. General de Planeación. Departamento de Estadística. Registro Estatal de Cáncer. Secretaria de Salud Jalisco. 2011; 12: 70. Disponible en: https://ssj.jalisco.gob.mx/sites/ssj.jalisco.gob.mx/ files/cancerbol_2011.pdf. 07/03/2018

  4. Francisco López-Köstner, Udo Kronberg, Alejandro J. Zárate. Programa de detección de neoplasias colorrectales en población mayor de 50 años. Revista Médica de Chile . 2012; 140: 140: 281-286.

  5. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-32.

  6. Scott R. Steele, MD. Tracy Hull, MD. Thomas Read, MD.Theodore Saclarides, MD. Anthony Senagore, MD. Charles Whitlow, MD. he ASCRS Textbook of Colon and Rectal Surgery. E.U.A.: Springer; 2016.

  7. Wina wer SJ. Natural history of colorectal cancer. American Journal of Medicine. 1999: 106.

  8. Rex DK, Johnson DA, JC Anderson JC, Schoenfeld Schoenfeld, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screen ing. AmJ Gastroenterol.2008:739-50.

  9. Oconnel JB. Maggard M, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Nat Cancer Inst; 2004:1420-5.

  10. American Health Organization. Cancer in the Americas. Basic Indicators, 2013. Pan American Health Organization. 2013; 5: 24. Disponible en: http://www.paho.org/hq/index.php?option=com_ content&view=article&id=9010:2013-canceramericas- country-profiles-2013&Itemid=40084.

  11. 11.James E . Allison , Lori C . et al. Screening for Colorectal Neoplasms With New Fecal Occult Blood. Tests: Update on Performance Characteristics. Journal National Cancer Institute. 2007; 99: 1462 – 70.

  12. 12.Jennifer S. Lin; Margaret A. Piper; Leslie A. Perdue; Carolyn M. Rutter; et al. Screening for Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(23): 2576-2594.

  13. 13.US Preventive Services Task Force. Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 315(23): 2564-2575.

  14. 14.NCCN Clinical Practice Guidelines in Oncology. Colorectal Cancer Screening. National Comprehensive Cancer Network. 11,14,2017: 56.

  15. 15.US Preventive Services Task Force. [Accessed 10/5, 2016] Final Recommendation Statement: Colorectal Cancer: Screening. 2016. Available at: https://www.uspreventiveservicestaskforce.org/Pa ge/Document/UpdateSummaryFinal/colorectalcancer- screening2

  16. 16.Winawer SJ, Schottenfeld D, Flehinger BJ. Colorectal cancer screening. J Natl Cancer Inst 1991;83:243–53.

  17. 17.Levin B LD, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, et al, American Cancer Society Colorectal Cancer Advisory Group,US Multi- Society Task Force, American College, Committee. oRCC. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology;2008(134):1570-95.

  18. 18.Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA. 2016;315: 2595-2609.

  19. 19.American Cancer Society. Colorectal Cancer Facts & Figures 2017-2019. Atlanta: American Cancer Society; 2017.

  20. 20.Shaan S. Patel, Meredith L. Kilgore, PhD. Cost Effectiveness of Colorectal Cancer Screening Strategies. Cancer Control. 04/01/2015: 248-258. Vol 22 No.2

  21. 21.Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 362:1795–803.

  22. 22.Fabrizio Stracci, Manuel Zorzi, Grazia Grazzini . Colorectal cancer screening: tests, strategies, and perspectives. Front. Public Health. 2014; 2: 1-9.

  23. 23.Alfred I. Neugut, Salvador Pita. Role of Sigmoidoscopy in Screening for Colorectal Cancer: A Critical Review. Gastroenterology. 1988; 95 No. 2: 492-499.

  24. 24.American Cancer Society. (2019). Guías de la Sociedad Americana Contra El Cáncer para la detección del cáncer colorrectal. 15/05/2019, de American Cancer Society SIitioweb: https://www.cancer.org/es/cancer/cancer-decolon- o-recto/deteccion-diagnostico-clasificacionpor- etapas/recomendaciones-de-la-sociedadamericana- contra-el-cancer.html

  25. 25.Kronborg O1, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. (1996 Nov 30). Randomised study of screening for colorectal cancer with faecal-occultblood test.

  26. 26.Pan American Health Organization. Cancer in the Americas. Basic Indicators, 2013. Pan American Health Organization. 2013; 5: 24. Disponible en: http://www.paho.org/hq/index.php?option=com_ content&view=article&id=9010:2013-canceramericas- country-profiles-2013&Itemid=40084. 07/03/2018.

  27. 27.Dra. Angélica Hernández . Academia Nacional de Medicina . YouTube . 25/03/2019. Disponible en: https://www. youtu.be/SF49GoTJmq4. 15/05/2019.mq4. 15/05/2019.




2020     |     www.medigraphic.com